Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Friday, June 13, 2025 · 821,962,913 Articles · 3+ Million Readers

Innovative Treatment Option for Depression Relief Now Available in Woburn

Northeast Health Services offers SPRAVATO®, FDA-approved nasal spray for treatment-resistant depression, providing fast, effective symptom relief.

WOBURN, MA, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- Northeast Health Services is thrilled to announce that its Woburn clinic is now offering Spravato® as part of its commitment to providing innovative and effective treatment options for mental health.

Northeast Health Services is proud to offer Spravato®, the first nasal spray approved by the FDA for treating adults with treatment resistant depression. Spravato®, also known as esketamine, is a fast-acting treatment, with clients often feeling relief from their depression symptoms within hours. It works by rapidly altering brain chemistry to provide relief from symptoms such as sadness, hopelessness, and loss of interest in activities. Historically Spravato® has been used in conjunction with an oral antidepressant; however, new FDA approval allows use of Spravato® without a concurrent oral antidepressant. Read more about this development here: https://www.jnj.com/media-center/press-releases/spravato-esketamine-approved-in-the-u-s-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression. Spravato® is administered at Northeast Health Services' approved clinics under the close supervision of a healthcare professional and is now more accessible than ever.

In a short-term study, patients treated with Spravato® combined with an oral antidepressant experienced a faster and more significant reduction in depression symptoms after just 4 weeks, compared to those who received the placebo alongside an oral antidepressant (https://www.spravato.com/how-spravato-could-help/). This innovative treatment option has been shown to be effective for many individuals who have not responded well to traditional antidepressant medications or talk therapy alone. Spravato® is not a cure for depression, but it can provide significant relief from symptoms and help individuals regain their quality of life.

To learn more about Northeast Health Services and its array of mental health services including individual and group therapy, TMS therapy, medication management, and Spravato® treatment, visit https://nehs.transformationsnetwork.com/schedule-appointment/. To schedule a new client appointment or to discuss how mental health treatment can benefit you, a loved one, or your patients, call 413-846-1848 or visit https://nehs.transformationsnetwork.com/schedule-appointment/.

About Northeast Health Services and Transformations Care Network  
Northeast Health Services is a proud member of Transformations Care Network (TCN). As a member of TCN, the Northeast Health Services team can accept more insurance plans and have access to cutting edge services and technological advancements. TCN provides the support, resources, and tools that your care team needs to transform lives in their communities. To learn more about Transformations Care Network, a family of outpatient mental health organizations, and the inspiring work they are doing to shape the future of mental health care, visit www.transformationsnetwork.com.  

Erica McPeek
Transformations Care Network
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release